Multiple Ascending Dose Phase I Study in Order to Define Lanifibranor (IVA337) Supra-thjerapeutic Dose

Clinical trial NCT03866369 · COMPLETED

Trial details

NCT number: NCT03866369
Sponsor: Inventiva Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2019-01-17
Primary completion: 2019-08-27
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.